Abstract:Abstract Tuberculosis (TB), caused by Mycobacterium tuberculosis bacteria, is a leading infectious cause of mortality worldwide, including in Pakistan. Drug resistant M. tuberculosis is an emerging threat for TB control, making it important to detect the underlying genetic mutations, and thereby inform treatment decision making and prevent transmission. Whole genome sequencing has emerged as the new diagnostic to reliably predict drug resistance within a clinically relevant time frame, and its deployment will have the greatest impact on TB control in highly endemic regions. To evaluate the mutations leading to drug resistance and to assess for evidence of the transmission of resistant strains, 81 M. tuberculosis samples from Khyber Pakhtunkhwa province (North West Pakistan) were subjected to whole genome sequencing and standard drug susceptibility testing for eleven anti-TB drugs. We found the majority of M. tuberculosis isolates were the CAS/Delhi strain-type (lineage 3; n = 57; 70.4%) and multi-drug resistant (MDR; n = 62; 76.5%). The most frequent resistance mutations were observed in the katG and rpoB genes, conferring resistance to isoniazid and rifampicin respectively. Mutations were also observed in genes conferring resistance to other first and second-line drugs, including in pncA (pyrazinamide), embB (ethambutol), gyrA (fluoroquinolones), rrs (aminoglycosides), rpsL, rrs and giB (streptomycin) loci. Whilst the majority of mutations have been reported in global datasets, we describe unreported putative resistance markers in katG , ethA (ethionamide), gyrA and gyrB (fluoroquinolones), and pncA . Analysis of the mutations revealed that acquisition of rifampicin resistance often preceded isoniazid in our isolates. We also observed a high proportion (17.6%) of pre-MDR isolates with fluoroquinolone resistance markers, potentially due to unregulated anti-TB drug use. Our isolates were compared to previously sequenced strains from Pakistan in a combined phylogenetic tree analysis. The presence of lineage 2 was only observed in our isolates. Using a cut-off of less than ten genome-wide mutation differences between isolates, a transmission analysis revealed 18 M. tuberculosis isolates clustering within eight networks, thereby providing evidence of drug-resistant TB transmission in the Khyber Pakhtunkhwa province. Overall, we have demonstrated that drug-resistant TB isolates are circulating and transmitted in North West Pakistan. Further, we have shown the usefulness of whole genome sequencing as a diagnostic tool for characterizing M. tuberculosis isolates, which will assist future epidemiological studies and disease control activities in Pakistan.

Comparative Genome Analysis of 2 Mycobacterium Tuberculosis Strains from Pakistan: Insights Globally Into Drug Resistance, Virulence, and Niche Adaptation.

Insight into the Drug Resistance Whole Genome of Mycobacterium Tuberculosis Isolates from Khyber Pakhtunkhwa, Pakistan.

Whole genome sequencing of drug resistant Mycobacterium tuberculosis isolates from a high burden tuberculosis region of North West Pakistan

Characterisation of drug-resistant Mycobacterium tuberculosis mutations and transmission in Pakistan

Comparative genome analysis reveals high-level drug resistance markers in a clinical isolate of Mycobacterium fortuitum subsp. fortuitum MF GZ001

Pangenomic analyses of tuberculosis strains to identify resistomes using computational approaches

Comparative Genomic Analysis of Two Clonally Related Multidrug Resistant Mycobacterium tuberculosis by Single Molecule Real Time Sequencing

Characterization of rifampicin-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan

Adaptive Gene Profiling of Mycobacterium Tuberculosis During Sub-Lethal Kanamycin Exposure

Diversity and novel mutations in membrane transporters of <i>Mycobacterium tuberculosis</i>

Identification of drug resistance-related virulence gene mutations in 667 clinical Mycobacterium tuberculosis isolates

Molecular Detection of Isoniazid, Rifampin and Ethambutol Resistance to M. Tuberculosis and M. Bovis in Multidrug Resistant Tuberculosis (MDR-TB) Patients in Pakistan.

Copy number variation analysis of 9,482 Mycobacterium tuberculosis isolates identifies lineage-specific molecular determinants.

Gene Expression Analysis of Two Extensively Drug-Resistant Tuberculosis Isolates Show That Two-Component Response Systems Enhance Drug Resistance

Genetic diversity, evolution and drug resistance of Mycobacterium tuberculosis lineage 2

Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis

Sequence Analysis of the Rifampicin Resistance Determining Region (RRDR) of Rpob Gene in Multidrug Resistance Confirmed and Newly Diagnosed Tuberculosis Patients of Punjab, Pakistan

Early detection of MDR Mycobacterium tuberculosis mutations in Pakistan

Comparative Genomic Analysis of Mycobacterium tuberculosis Drug Resistant Strains from Russia

The Bioinformatics Analysis Of Comparative Genomics Of Mycobacterium Tuberculosis Complex (Mtbc) Provides Insight Into Dissimilarities Between Intraspecific Groups Differingin Host Association, Virulence, And Epitope Diversity

Multi-drug resistant gene mutation analysis in Mycobacterium tuberculosis by molecular techniques